PolyActiva Expands Executive Team to Drive Transformational Growth and Advance Late-Stage Clinical Development in the U.S. [Yahoo! Finance]
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: Yahoo! Finance
FORT WORTH, Texas & MELBOURNE, Australia, July 16, 2025 BUSINESS WIRE PolyActiva , a clinical-stage biopharmaceutical company pioneering a novel drug delivery technology to improve outcomes for patients with ocular conditions, today announced the appointments of Wes Brazell as Chief Financial Officer (CFO) and Michael Brubaker, PhD, as Chief Scientific Officer (CSO). "Wes and Mike bring exceptional expertise in their respective fields and a shared commitment to innovation and value creation in ophthalmology," said Jerry St. Peter, CEO and Board Director of PolyActiva. "Their appointments come at an important time as we scale globally and advance our lead product candidate, PA5108, into late-stage clinical development. Alongside Vanessa Waddell's continued leadership as Chief Strategy Officer, we're building a highly capable executive team to guide our next phase of growth. These appointments enhance our deep technical foundation in Australia and position us to deliver on our missio
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- What Abbott Laboratories (ABT)'s New Pediatric Heart Device Clearances Mean For Shareholders [Yahoo! Finance]Yahoo! Finance
- ??????????? ???????? - ??????????????????2026-2035? [CNET News]CNET News
- Abbott (ABT): Assessing Valuation After New Regulatory Wins for Its Pediatric Heart Device Innovation [Yahoo! Finance]Yahoo! Finance
- Can Abbott Laboratories (ABT) Deliver Resilient Returns in the Long Term? [Yahoo! Finance]Yahoo! Finance
- Abbott's Amplatzer Piccolo™ Delivery System Receives FDA Clearance and CE Mark to Optimize Procedures for Premature Babies With a Hole in the Heart [Yahoo! Finance]Yahoo! Finance
ABT
Earnings
- 10/15/25 - In-Line
ABT
Sec Filings
- 12/19/25 - Form 3
- 12/12/25 - Form 4
- 12/12/25 - Form 8-K
- ABT's page on the SEC website